SZSE:002750 (China)
Â
Class A
Â¥
2.75
(-4.84%)
May 28
Business Description
Kunming Longjin Pharmaceutical Co Ltd
ISIN : CNE1000021X8
Share Class Description:
SZSE:002750: Class ACompare
Compare
Traded in other countries / regions
002750.China IPO Date
2015-03-24Description
Kunming Longjin Pharmaceutical Co Ltd is a pharmaceutical company. It develops, produces and sells natural botanical and chemical freeze-dried powder injections. It also has freeze-dried powder injection line. Its products include Chinese medicine, biochemical medicine, chemical medicine, cardio-cerebral vascular medicine, digestive system medicine, immune system medicine, vitamins, minerals, enteral and parenteral nutrition.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 30.8 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.19 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 7.39 | |||||
| Beneish M-Score | -2.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -30.2 | |||||
| 3-Year EPS without NRI Growth Rate | -223.4 | |||||
| 3-Year FCF Growth Rate | -21.7 | |||||
| 3-Year Book Growth Rate | -7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.4 | |||||
| 9-Day RSI | 9.14 | |||||
| 14-Day RSI | 15.31 | |||||
| 6-1 Month Momentum % | -47.73 | |||||
| 12-1 Month Momentum % | -41.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.97 | |||||
| Quick Ratio | 5.57 | |||||
| Cash Ratio | 5.13 | |||||
| Days Inventory | 309.24 | |||||
| Days Sales Outstanding | 63.42 | |||||
| Days Payable | 110.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.19 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.38 | |||||
| Operating Margin % | -64.04 | |||||
| Net Margin % | -73.61 | |||||
| FCF Margin % | -21.15 | |||||
| ROE % | -12.38 | |||||
| ROA % | -10.08 | |||||
| ROIC % | -21.85 | |||||
| ROC (Joel Greenblatt) % | -31.03 | |||||
| ROCE % | -9.48 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 68.75 | |||||
| PS Ratio | 12.06 | |||||
| PB Ratio | 2.17 | |||||
| Price-to-Tangible-Book | 2.46 | |||||
| EV-to-EBIT | -14.35 | |||||
| EV-to-EBITDA | -14.35 | |||||
| EV-to-Revenue | 9.08 | |||||
| EV-to-FCF | -46.01 | |||||
| Price-to-Projected-FCF | 5.98 | |||||
| Price-to-Net-Current-Asset-Value | 4.23 | |||||
| Price-to-Net-Cash | 5.39 | |||||
| Earnings Yield (Greenblatt) % | -6.97 | |||||
| FCF Yield % | -1.76 | |||||
| Forward Rate of Return (Yacktman) % | -28.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kunming Longjin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 91.456 | ||
| EPS (TTM) (Â¥) | -0.168 | ||
| Beta | 1.03 | ||
| Volatility % | 42.12 | ||
| 14-Day RSI | 15.31 | ||
| 14-Day ATR (Â¥) | 0.268406 | ||
| 20-Day SMA (Â¥) | 4.3655 | ||
| 12-1 Month Momentum % | -41.92 | ||
| 52-Week Range (Â¥) | 2.75 - 12.5 | ||
| Shares Outstanding (Mil) | 400.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kunming Longjin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kunming Longjin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kunming Longjin Pharmaceutical Co Ltd Frequently Asked Questions
What is Kunming Longjin Pharmaceutical Co Ltd(SZSE:002750)'s stock price today?
The current price of SZSE:002750 is ¥2.75. The 52 week high of SZSE:002750 is ¥12.50 and 52 week low is ¥2.75.
When is next earnings date of Kunming Longjin Pharmaceutical Co Ltd(SZSE:002750)?
The next earnings date of Kunming Longjin Pharmaceutical Co Ltd(SZSE:002750) is .
Does Kunming Longjin Pharmaceutical Co Ltd(SZSE:002750) pay dividends? If so, how much?
Kunming Longjin Pharmaceutical Co Ltd(SZSE:002750) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers